Matthew P. Ottmer has sold VYGR and made no open-market buys since Jan 2020
COO at Voyager Therapeutics, Inc.
SEC CIK 0001659870 · Filings on SEC.gov ↗
$0Bought
$50KSold
NoneLast buy
Every filing
1 filing since Jan 2020, newest first
Filings come from SEC EDGAR. Not investment advice.